Lemons and Lyme by Stanley Plotkin
SEP 20, 2018 —
A copy of the letter below was forwarded to the Tick Borne Disease Working Group as the information currently published is an extension of the thirty year racketeering scheme. The mishandling of Lyme disease can be traced back to vaccine development when the infection was classified as “easily diagnosed and treated” Publications prior to Dearborn (1994) painted an entirely different picture. One of those publications from 1977 is highlighted below.
The picture attached to this update was found at the following Wikipedia Plotkin page: https://en.wikipedia.org/wiki/Stanley_Plotkin
Letter to Stanley Plotkin regarding the Lyme vaccine:
———- Original Message ———-
From: Carl Tuttle <firstname.lastname@example.org>
Cc: email@example.com, firstname.lastname@example.org, email@example.com, firstname.lastname@example.org, email@example.com, JPIDS.EditorialOffice@oup.com
Date: September 19, 2018 at 9:48 AM
Subject: Lemons and Lyme by Stanley A. Plotkin
Journal of the Pediatric Infectious Diseases Society
13 September 2018 P L O T K I N C O L U M N
Lemons and Lyme
Stanley A. Plotkin
Emeritus Professor of Pediatrics, University of Pennsylvania, Doylestown
“It is odd that there is a lobby against the development and deployment of a vaccine against the disease by people who think they are suffering from Lyme infection in a chronic form, the existence of which remains doubtful. They believe that the first vaccine against Lyme disease caused chronic arthritis.”
Sept 19, 2018
Perelman School of Medicine
University of Pennsylvania
3400 Civic Center Boulevard Building 421
Philadelphia, PA 19104
“It is odd” that the two principal investigators of the previous Lyme vaccines, Allen Steere for SmithKlineBeecham’s LymeRix and Gary Wormser for Connaught’s vaccine (which never made it to market) have been named in a racketeering lawsuit. (See attached court document)
It is believed that Lyme disease was pigeonholed into its current status by the two principal investigators of the previous Lyme disease vaccines as these investigators conceptualized a disease that would enable vaccine development.
A preventive vaccine for Lyme disease would not satisfy the FDA if a chronic persistent infection and seronegative disease exist. The lead author of the one-size-fits-all IDSA Lyme treatment guideline (which matches the conceptualized disease) was the principal investigator of Connaught’s Lyme vaccine, Dr. Gary Wormser. This is a flagrant conflict of interest. Have we been dealing with an antibiotic resistant/tolerant superbug purposely concealed to promote vaccine development?
Forty one years ago Allen Steere knew that antibiotics used to treat Lyme disease were not working:
Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three connecticut communities. (1977)
Steere AC, Malawista SE, Snydman DR, Shope RE, Andiman WA, Ross MR, Steele FM.
“The best treatment for this illness is not clear. Some physicians have reported that penicillin or tetracycline results in disappearance of the skin lesion (41,42), but others find antibiotics ineffective. Four of the patients with expanding skin lesions received penicillin but still developed arthritis.”
A PubMed.gov search will find hundreds of papers reporting persistent Borrelia infection.
I would like to point out the following 1995 case study from Stony Brook Lyme clinic. I understand the patient received thirteen spinal taps, multiple courses of IV and oral meds, and relapsed after each one, proven by CSF antigens and/or PCR. The only way this patient (said to be a physician) remained in remission was to keep her on open ended clarithromycin- was on it for 22 months by the time of publication.
Seronegative Chronic Relapsing Neuroborreliosis.
Lawrence C.a · Lipton R.B.b · Lowy F.D.c · Coyle P.K.d
aDepartment of Medicine, bDepartment of Neurology, and cDivision of Infectious Diseases, Albert Einstein College of Medicine, and dDepartment of Neurology, State University of New York at Stony Brook, New York, NY., USA
Eur Neurol 1995; 35:113–117 (DOI:10.1159/000117104)
We report an unusual patient with evidence of Borrelia burgdorferi infection who experienced repeated neurologic relapses despite aggressive antibiotic therapy. Each course of therapy was associated with a Jarisch-Herxheimer-like reaction. Although the patient never had detectable free antibodies to B. burgdorferi in serum or spinal fluid, the CSF was positive on multiple occasions for complexed anti-B. burgdorferi antibodies, B. burgdorferi nucleic acids and free antigen.
The following pilot study recently identified chronic Lyme disease in twelve patients from Canada. All of these patients were culture positive for infection (genital secretions, skin and blood) even after multiple years on antibiotics so there was no relief from current antimicrobials. Some of these patients had taken as many as eleven different types of antibiotics.
Persistent Borrelia Infection in Patients with Ongoing Symptoms of Lyme Disease
Dr. Plotkin, your commentary published in the Journal of the Pediatric Infectious Diseases Society is little more than perpetuation of a thirty year racketeering scheme to suppress evidence of persistent infection for the purpose of vaccine development. An astute fifth grader with access to PubMed could uncover this blatantly obvious charade.
Lyme Endemic Hudson, NH
Attachment: Lyme Disease RICO Lawsuit Court Document
Cc: Theoklis Zaoutis, MD, MSCE EDITOR-IN-CHIEF
Julie Weber-Roark MANAGING EDITOR
Attorney Daniel Dutko of Hanszen Laporte
The Honorable Chris Smith and Collin Peterson